Brigham and Women's Hospital investigators link very high lipoprotein(a) with a higher 30-year risk of major cardiovascular ...

Comparing extremes of the spectrum, multivariable analyses generally showed significantly higher risks for patients with high lipoprotein (a) levels versus low levels (>120 mg/dL vs <10 mg/dL) or when ...

Find out how lipoprotein(a) screening identifies women at long term cardiovascular risk and supports earlier prevention ...

Every Australian adult should be screened for a potentially deadly type of inherited cholesterol, and if the simple blood ...

Dennis R. Leahy, MD, shares his POV on the value of making Lp(a) testing universal, not only to inform patients and their clinicians of the high CV risks, but to make way for potential treatments.

Fast-growing commercial-stage diagnostics company numares AG today announced the worldwide launch of its new, software-based test insightLP™-S50, part of the Company’s lipoFIT® series for lipoprotein ...

NEW YORK--(BUSINESS WIRE)--LetsGetChecked, a global healthcare solutions company, today announced its collaboration with Novartis to increase access to Lipoprotein(a)–Lp(a)–testing and programs. Now, ...

Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

Review in The Lancet finds that one in five globally are at risk of contracting cardiovascular diseases, because they carry a genetic risk of high levels of a specific lipoprotein, which can be tested ...

Please provide your email address to receive an email when new articles are posted on . Martin, a cardiologist at Johns Hopkins Hospital, professor of medicine at Johns Hopkins University School of ...

Up to 30% of people have some degree of statin intolerance, according to research published in the Journal of Clinical Lipidology. Test your heart health knowledge and learn more about managing your ...

LipoScience, Inc., LPDX a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and ...